DCF — ENCOMPASS HEALTH REHABILITATION HOSP
Enterprise Value: $6.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$6.3M
Enterprise Value
$1.0M
PV of Cash Flows
$5.3M
PV of Terminal Value
$8.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $34.8M | $1.5M | 4.0% | $-0.2M | $-0.1M |
| Year 2 | $35.8M | $1.9M | 5.0% | $0.1M | $0.1M |
| Year 3 | $36.9M | $2.3M | 6.0% | $0.4M | $0.3M |
| Year 4 | $38.0M | $2.5M | 7.0% | $0.5M | $0.4M |
| Year 5 | $39.2M | $2.7M | 7.0% | $0.6M | $0.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $6.3M. Terminal value accounts for 84% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$33.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.036893876918028194
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5